Supporting people in hospitals across South Australia through vital health and medical research and improved patient care.
Meet our passionate and dedicated team.
Meet our Board and Governance team.
THRF adopts extremely high transparency standards when reporting our financials.
Supports research into the detection, management and treatment of breast cancer.
Funds vital medical research into the detection and treatment of prostate cancer, as well as preventing the metastatic spread of the disease.
We are passionate and determined to improve heart health and beat heart disease through advances in knowledge and research.
Our aim is to reduce and ultimately eliminate the high incidence of chronic kidney disease and diabetes in Australia and around the world.
Supports health and wellbeing research for veterans, emergency service personnel and their families.
Driving collaboration, innovation and research to develop best-practice arts, design and health programs.
Supporting world-class stroke research to improve prevention, diagnosis and acute treatment to cure stroke.
Do you want to join our team? Check out current career opportunities here.
View some of the commonly asked questions about our organisation.
We are so grateful to those who donate their time and skills to support life-changing medical research. Find out more…
Get in touch with us here.
“Eczema doesn’t kill you, it kills your life.”
At the young age of four months, Robert Kenrick’s daughter Martha was diagnosed with eczema. For Robert, this meant rubbing his daughter’s back for almost an hour at night to help her get to sleep because her skin was so itchy. It meant seeing her fall behind in school as she wasn’t getting the amount of sleep a young child needs. It changed not only Martha’s life, but that of Robert and his wife, Euphemia.
Hearing about the life-changing allergy research of Dr Dave Yip from the Centre for Cancer Biology (CCB), Robert was beyond thrilled to learn research was underway to help improve Martha’s life and that of so many other Australians like her. Robert has committed to funding Dr Yip’s research for three years through The Hospital Research Foundation (THRF), confident he could develop a better treatment for eczema.
“All through Martha’s childhood, from the age of about four months, her eczema kept recurring. It would appear on her back, to behind her legs and sometimes all over. Everything we gave her to eat she seemed to be reacting to,” Robert said.
“Between the ages of three and six she wasn’t sleeping well because she was itchy, so we had to rub her back for about 45 minutes until she fell asleep, then again when she woke up in the middle of the night,” Robert said.
Robert and Euphemia managed to control Martha’s eczema in Year 1 by eliminating foods to which she was sensitive from her diet on a rotational basis.
“It wasn’t fun but it worked. I remember the joy when, three weeks after we started the diet, Martha slept through the night for the first time in months.”
However the eczema came back with a vengeance when she was in Year 10.
“It was the beginning of her SACE course so we think it was a reaction to stress. It limited what she could do as a normal teenager with her friends, she couldn’t wear the same clothes for fear of showing the rash and she got itchy whenever she exercised,” Robert said.
Now 24-years-old and graduated from her nursing degree, Martha manages her eczema with steroid cream and moisturiser which she has to apply on a daily basis.
“There is no good treatment for eczema. The standard approach is to stick patients on steroid creams, but the cream only helps your skin heal, it doesn’t stop the eczema from coming back.”
Despite allergies being the fastest growing chronic condition in Australia, steroid cream is one of the only treatment options for people like Martha, with the cream unfortunately having its own side effects.
Now armed with Robert’s support through THRF, Dr Yip is confident his research could see a new treatment for eczema that doesn’t lead to side effects like that of steroid cream.
Dr Yip is investigating mast cells, which reside in human tissue and play a crucial role in triggering allergic responses, like a rash for people with eczema. He is studying these mast cells to determine how they can be controlled to stop them triggering this allergic response but keep their positive functions within the body.
Determined to see a future free of steroid creams and other daily necessities for his daughter, Robert is confident Dr Yip and his team’s research at the CCB could be a game changer for eczema treatment.
“Having eczema has impacted Martha’s entire life, so the prospect of her not having to use this steroid cream again is very exciting. I’m extremely hopeful.”
THRF prides ourselves in helping donors like Robert donate to research areas they are passionate about. If you have an area of research you would like to donate to, please call us on (08) 8244 1100 or email us at email@example.com.
With the support of our Development Grant of $200,000 Professor Peter-John Wormald and his team are translating a gel now used to treat inflammation after sinus infection to a new treatment for people living with chronic pain after back surgery. read more
Three years ago Katharina Richter started her PhD with a determination to improve the lives of people living with a debilitating condition, Chronic Rhinosinusitis (CRS). We’re very pleased to share that she’s achieved just that! read more
For many years Martin Darling suffered from chronic headaches taking a huge toll on his everyday life. The good news is medical research changed his life! read more
The World Health Organisation predicts by 2050 superbugs will be the cause of 10 million deaths each year. This is far more deaths than from cancer and diabetes combined.
Superbugs are antibiotic resistant bacteria, and Dr Nicky Thomas and his team are in a race against time to halt them in their tracks.
On the final night of local festival supported by THRF, Pint of Science, the audience was treated to a very special guest speaker, Associate Professor Tom Coenye who travelled all the way from Belgium! read more
Aden’s research is focused on Chronic Rhinosinusitis (CRS), a disease which affects more than 10 per cent of the Australian population. read more
German born and educated with research and work experience stints in New Zealand, Switzerland and Denmark, Katharina Richter is now hoping to change the lives of those suffering from chronic rhinosinusitis (CRS) through her PhD at the Basil Hetzel Institute for Translational Health Research (BHI). read more
Since his teenage years, 27-year-old Patrick Guerin has been used to an absent sense of smell and taste. A stuffy nose, pressure headaches, tiredness and feeling under the weather were part of his daily life. Patrick suffers with chronic rhinosinusitis. read more